Ankylosing Spondylitis 2022 Industry Share, Investment Trends, Growth, Size, Strategy Research Report

Submitted by: Submitted by

Views: 10

Words: 522

Pages: 3

Category: Business and Industry

Date Submitted: 10/07/2015 03:59 AM

Report This Essay

Hexa Reports

Market Research Reports and Insightful Company Profiles

EpiCast Report: Ankylosing Spondylitis Epidemiology Forecast Global Share and Size, Trends,

Growth, Analysis and Forecasts, 2015 to 2024

EpiCast Report: Ankylosing Spondylitis - Epidemiology Forecast to 2024

Summary

Ankylosing spondylitis (AS) - a systemic, chronic, and progressive inflammatory arthritis, is the prototype

of a family of related disorders known as seronegative spondyloarthritis (SpA) and one of the most

common rheumatic diseases across the globe. AS primarily affects the spine and sacroiliac (SI) joints and

progresses into severe inflammation that fuses the spine, leading to permanent painful stiffness of the

back. AS that occurs before any structural changes in the spine is referred to as non-radiographic axial

spondyloarthritis (nr-axSpA) which is the early stage of AS. Some of non-radiographic axial

spondyloarthritis progress to AS and some do not.

Browse Detail Report With TOC @ http://www.hexareports.com/report/epicast-report-ankylosingspondylitis-epidemiology-forecast-to-2024/details

Scope

- The Ankylosing Spondylitis EpiCast Report provides an overview of the risk factors, comorbidities, and

global trends for ankylosing spondylitis (AS) in the seven major markets (7MM) (US, France, Germany,

Italy, Spain, UK, Japan). It includes a 10-year epidemiological forecast of the diagnosed prevalent cases

of ankylosing spondylitis segmented by sex, age (in ten-year increments beginning at 15 years and

Hexa Reports

Market Research Reports and Insightful Company Profiles

ending at =65 years), and diagnosed prevalent cases of non-radiographic axial spondyloarthritis, and

diagnosed prevalent cases of AS segmented by HLA-B27 seropositivity status in these markets.

- The ankylosing spondylitis epidemiology report is written and developed by Masters- and PhD-level

epidemiologists.

- The EpiCast Report is in-depth, high quality, transparent and market-driven,...